financetom
Business
financetom
/
Business
/
Games Global Ltd withdraws US IPO plan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Games Global Ltd withdraws US IPO plan
May 13, 2024 1:13 PM

May 13 (Reuters) - Games Global ( GGL ), the UK-based maker of

online casino-styled games, withdrew its plan for an initial

public offering in the United States on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SocGen Comments on Indian Economy, Rupee as U.S. Tariffs Take Effect
SocGen Comments on Indian Economy, Rupee as U.S. Tariffs Take Effect
Aug 27, 2025
07:27 AM EDT, 08/27/2025 (MT Newswires) -- The additional 25% United States tariff on Indian imports come into effect on Wednesday for the country's purchase of Russian oil, noted Societe Generale. This comes on top of the 25% reciprocal tariffs and lifts the effective tariff to 50%, wrote the bank in a note to clients. SocGen has already pointed out...
Market Chatter: Newmont Planning Job Cuts to Lower Costs
Market Chatter: Newmont Planning Job Cuts to Lower Costs
Aug 27, 2025
07:27 AM EDT, 08/27/2025 (MT Newswires) -- Newmont ( NEM ) could cut its headcount by thousands as it aims to reduce costs, which have soared following its acquisition of Newcrest Mining in 2023, Bloomberg reported Wednesday, citing people familiar with the matter. Newmont ( NEM ) has informed managers it wants costs to be closer to those incurred by...
Merck's Phase 3 Trial for Metastatic Breast Cancer Treatment Doses First Patient
Merck's Phase 3 Trial for Metastatic Breast Cancer Treatment Doses First Patient
Aug 27, 2025
07:28 AM EDT, 08/27/2025 (MT Newswires) -- Merck ( MRK ) said Wednesday its phase 3 trial for investigational patritumab deruxtecan targeting metastatic breast cancer has dosed its first patient. The trial evaluates the efficacy and safety of investigational patritumab deruxtecan versus investigator's choice of treatment in patients with unresectable locally advanced or metastatic hormone receptor positive, HER2 negative breast...
Kohl's Fiscal Q2 Adjusted Earnings, Net Sales Fall; 2025 Outlook Revised
Kohl's Fiscal Q2 Adjusted Earnings, Net Sales Fall; 2025 Outlook Revised
Aug 27, 2025
07:29 AM EDT, 08/27/2025 (MT Newswires) -- Kohl's (KSS) reported fiscal Q2 adjusted earnings Wednesday of $0.56 per diluted share, down from $0.59 a year earlier. Analysts polled by FactSet expected $0.30. Net sales for the quarter ended Aug. 2 were $3.35 billion, compared with $3.53 billion a year earlier. Analysts surveyed by FactSet expected $3.32 billion. For fiscal 2025,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved